News | Stents

October 1, 2020 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for new one-month of dual ...

Home October 01, 2020
Home
News | Optical Coherence Tomography (OCT)

October 1, 2020 — A team of researchers led by the University of Adelaide and University of Stuttgart has used 3-D micro ...

Home October 01, 2020
Home
The two top DAIC stories in September included the use of point-of-care ultrasound (POCUS) to perform echocardiograms of COVID-19 patients rather than wheeling in larger systems that are more difficult to sanitize. The second top story was on a new trial for Abbott's bioresorbable stent for below-the-knee (BTK) peripheral artery disease lesions. This is a resumption of bioresorbable stent clinical research since the Absorb stent was taken off the market in 2017.
Feature | Dave Fornell, Editor

October 1, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home October 01, 2020
Home
Videos | EP Lab

Peter Weiss M.D., MSc, director of ventricular arrhythmia management and robotics, and assistant clinical professor of ...

Home September 30, 2020
Home
News | Wearables

September 30, 2020 — In today’s digital age, focus on digital health and the quantified self have led to the rapid rise ...

Home September 30, 2020
Home
Videos | Coronavirus (COVID-19)

Deepika Thacker, M.D., a pediatric cardiologist with Nemours Children’s Health System, Wilmington, Del., helped discover ...

Home September 29, 2020
Home
News | Coronavirus (COVID-19)

September 29, 2020 – Extracorporeal membrane oxygenation (ECMO) support saved lives in past epidemics of lung-damaging ...

Home September 29, 2020
Home
News | EP Mapping and Imaging Systems

September 29, 2020 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the second-generation of ...

Home September 29, 2020
Home
The artificial intelligence-driven Caption Guidance software guides point of care ultrasound (POCUS) users to get optimal cardiac ultrasound images. The AI software is an example of a FDA-cleared software that is helping improve imaging, even when used by less experienced users.
Feature | Artificial Intelligence | Joe Fornadel, J.D., and Wes Moran, J.D.

The number of Federal Drug Administration (FDA)-approved AI-based algorithms is significant and has grown at a steady ...

Home September 29, 2020
Home
News | Heart Valve Technology

September 29, 2020 — Boston Scientific launched the Acurate neo2 transcatheter aortic valve replacement (TAVR) system in ...

Home September 29, 2020
Home
Videos | Artificial Intelligence

Ernest Garcia, Ph.D., MASNC, FAHA, endowed professor in cardiac imaging, director of nuclear cardiology R&D laboratory ...

Home September 25, 2020
Home
News | Coronavirus (COVID-19)

September 25, 2020 — Short-term hydroxychloroquine treatment is not associated with lethal heart rhythms in patients ...

Home September 25, 2020
Home
News | Wearables

September 25, 2020 — Remote and in-hospital wearable biosensor technology company VitalConnect Inc. has started the ...

Home September 25, 2020
Home
News | Thrombectomy Devices

September 25, 2020 — Philips Healthcare launched its QuickClear mechanical thrombectomy system. The compact, single-use ...

Home September 25, 2020
Home
News | Cardiovascular Ultrasound

September 25, 2020 — Based on its recent analysis of the global artificial intelligence (AI)-based echocardiography ...

Home September 25, 2020
Home
Subscribe Now